+44 115 974 9000
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world
We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Translational Pharmaceutics® accelerates drug development by integrating formulation development, real-time manufacturing and clinical testing. The platform is unique to Quotient Sciences and has been used over the last decade by global pharmaceutical and biotech companies across over 400 drug programs.
Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development.
Understanding that early phase clinical testing is a pivotal milestone in the development of your drug product, Quotient offers a clinical trial manufacturing, testing and certification service designed to meet your individual requirements. Our innovative method of building integrated GMP and GCP programs provides you with a streamlined, flexible approach to drug product supply that reflects your clinical study design and timeline. We understand the time and cost pressures you face during early phase evaluation and work with you to ensure a rapid, seamless path from development to clinical trial supply.
When you are looking for a partner who is dedicated to Phase I trials and early clinical development, rely on Quotient Sciences for the experience and expertise to seamlessly deliver your studies with the highest quality service and speed. We accelerate your molecule from first-in-human to proof-of-concept, helping you make critical decisions earlier and faster. Whatever Phase I clinical pharmacology study you require, you can expect a fully integrated program from study design and start-up to data reporting.
Quotient Sciences is a global player in commercial drug product manufacture of small molecule products for niche therapies including oncology and orphan drugs. Our commercial manufacturing facility located in Philadelphia is designed to handle your high-potency compounds.
Download the white paper 'Assessing the Financial Impact of Translational Pharmaceutics'
In partnership with @Quotient_Sci, we have started a GMP campaign to begin the first human trial of a CESS® nanoformed™ drug candidate by year-end 2020. An investor teleconference will be held to discuss the news on 21.10.20 at 10.45 a.m. EEST. Read on:https://t.co/kcKQe5iuNO pic.twitter.com/nxNWLGZVAk— Nanoform (@NanoformF) October 20, 2020
Check out our LIVE webcast w/ @Quotient_Sci!— PharmTech Group (@PharmTechGroup) October 20, 2020
"Advancing the Pharmaceutical Development of Orphan Drugs for Rare Diseases" on Wednesday, October 28, 2020 at 11am EDT| 8am PDT| 3pm GMT| 4pm CEThttps://t.co/00WSyWE4J3 pic.twitter.com/R7T2XPcfUv